Medizinische Universität Wien

Individually Stabilized, Superparamagnetic Nanoparticles with Controlled Shell and Size Leading to Exceptional Stealth Properties and High Relaxivities (2017) Lassenberger A, Scheberl A, Stadlbauer A, Stiglbauer A, Helbich T, Reimhult E Journal article Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) (2017) Loibl S, De La Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, et al. Journal article Prognostic Value of "Prepectoral Edema" in MR-mammography (2017) Kaiser CG, Herold M, Krammer J, Baltzer P, Gajda M, Camara O, Schoenberg S, et al. Journal article MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications (2017) Bennani-Baiti B, Dietzel M, Baltzer PA Journal article A new method to reduce false positive results in breast MRI by evaluation of multiple spectral regions in proton MR-spectroscopy (2017) Clauser P, Marcon M, Dietzel M, Baltzer PAT Journal article Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R) (2017) Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, et al. Journal article ADF Winter School-An exciting concept of the Arbeitsgemeinschaft Dermatologische Forschung to connect young scientists and clinician scientists in Dermatology at the top of Germany (2017) Yazdi AS, Barlin M, Boehm K, Gendrisch F, Ghorbanalipoor S, Haeberle S, Hamel A, et al. Journal article, other Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R (2017) Mehilli J, Achenbach S, Woehrle J, Baquet M, Riemer T, Muenzel T, Nef HM, et al. Journal article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide autogel/depot 120mg in the CLARINET open-label extension (2017) Cwikla JB, Wolin EM, Pavel ME, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution "AND SUDDENLY YOU ARE A PERSON AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS!" DIFFERENT PERSPECTIVES OF INDIVIDUALS ON PREDICTIVE TESTING - RESULTS OF AN INTERNATIONAL QUALITATIVE INTERVIEW STUDY (2017) Mosor E, Stoffer M, Steiner G, Raza K, Stack RJ, Simons G, Falahee M, et al. Conference contribution